Last updated 16 days ago
REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels
7000 patients around the world
Available in Argentina, Mexico, United States, Colombia, Brazil, Spain
Novo Nordisk A/S
40Research sites
7000Patients around the world
This study is for people with
Cardiovascular disease
Established cardiovascular disease
Obesity
Requirements for the patient
From 55 Years
All Gender
Medical requirements
Sites
Centro de Investigaciones Metabólicas (CINME) S.A. - CABA, Buenos Aires
Recruiting
Instituto de Investigaciones Clínicas Mar del Plata
Recruiting
Instituto de Investigaciones Clínicas San Nicolás
Recruiting
Instituto Médico Damic S.R.L.
Recruiting
Sanatorio Norte SRL - Santiago del Estero
Recruiting
Mautalen - Salud e Investigación - CABA
Recruiting
Instituto Medico Catamarca "IMEC"
Recruiting
Centro Medico de Nutrición y Diabetes (CENUDIAB)
Recruiting
Consultorio Integral de Atención al Diabético CIAD Morón
Recruiting
Hospital Italiano de La Plata
Recruiting
StudyREDEFINE 3
SponsorNovo Nordisk A/S
Study typeInterventional
Conditions
Established cardiovascular disease
Requirements
From 55 YearsAll Gender
Unique study IDclinicaltrials.gov
NCT05669755
